MARKET

INVO

INVO

INVO Bioscience
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.100
-0.040
-1.27%
Opening 11:30 01/20 EST
OPEN
3.120
PREV CLOSE
3.140
HIGH
3.200
LOW
3.000
VOLUME
58.20K
TURNOVER
--
52 WEEK HIGH
13.68
52 WEEK LOW
2.800
MARKET CAP
29.64M
P/E (TTM)
-2.8829
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
INVO Bioscience +4%, seeks infertility care expansion in Pakistan
INVO Bioscience (INVO) enters an exclusive distribution agreement with Galaxy Pharma to distribute the INVOcell system within Pakistan.Galaxy Pharma is a leader in providing products and services to the country's current full-service In Vitro
Seekingalpha · 5d ago
INVO Biosciences Expands Distribution Of INVOcell Into The Pakistan Infertility Market With Galaxy Pharma
INVO Bioscience Expands Distribution of INVOcell Into the Pakistan Infertility Market with Galaxy Pharma Ltd. SARASOTA, Fla., Jan. 15, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ:INVO), a
Benzinga · 5d ago
INVO Bioscience Expands Distribution of INVOcell Into the Pakistan Infertility Market with Galaxy Pharma Ltd.
, /PRNewswire/ -- a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, today announced it has entered an e...
PR Newswire - PRF · 5d ago
INVO Bioscience Management Letter to Shareholders
, /PRNewswire/ --  (NASDAQ: INVO) a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System, INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, is pleased to provide a y...
PR Newswire - PRF · 01/07 14:00
INVO Bioscience, idsMED Group Enter Distribution Agreement For Malaysia
INVO Bioscience and idsMED Group Enter Distribution Agreement for Malaysia SARASOTA, Fla., Nov. 25, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ:INVO) (the
Benzinga · 11/25/2020 14:02
INVO Bioscience and idsMED Group Enter Distribution Agreement for Malaysia
SARASOTA, Fla., /PRNewswire/ -- (Nasdaq: INVO)developers of INVOcell®, the world's only in vivo Intravaginal Culture System, entered into an exclusive distribution agreement with idsMED Group to distribute the INVOcell system to . idsMED, with its extensive distribution network, is one of the leading integrated medical solutions providers of equipment, consumables and services in .
PR Newswire - PRF · 11/25/2020 14:00
INVO Bioscience and idsMED Group Enter Distribution Agreement for Malaysia
SARASOTA, Fla., /PRNewswire/ -- (Nasdaq: INVO)developers of INVOcell®, the world's only in vivo Intravaginal Culture System, entered into an exclusive distribution agreement with idsMED Group to distribute the INVOcell system to . idsMED, with its extensi...
PR Newswire - PRF · 11/25/2020 14:00
INVO Bioscience Reports Formation Of Scientific Advisory Board
INVO Bioscience, Inc. (NASDAQ:INVO) developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced the formation of its Scientific Advisory Board (SAB) with the appointment of
Benzinga · 11/18/2020 14:20
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of INVO. Analyze the recent business situations of INVO Bioscience through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Institutional Holdings
Institutions: 2
Institutional Holdings: 60.03K
% Owned: 0.63%
Shares Outstanding: 9.56M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.52%
Healthcare Equipment & Supplies
+0.64%
Key Executives
Chief Executive Officer/Director
Steven Shum
Chief Financial Officer
Debra Hoopes
Chief Operating Officer/Vice President - Business Development
Michael Campbell
Vice President
Britt Carlsson
Independent Director
Stephen Shum
Vice President
Lori Kahler
Director
Kevin Doody
Director
Barbara Ryan
Director
Jeffrey Segal
Director
Matthew Szot
Independent Director
Trent Davis
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About INVO
INVO Bioscience, Inc. is a medical device company. The Company is focused on creating various treatments for patients diagnosed with infertility. The Company's product, the INVOcell, is a medical device used in infertility treatment and is considered as an assisted reproductive technology (ART). INVOcell is an intravaginal culture (IVC) system used for preparing, holding and transferring human gametes or embryos during vaginal in vitro fertilization or intravaginal culture procedures (IVF/IVC). The INVOcell system consists of various components: INVOcell Culture Device, INVOcell Retention Device and INVOcell Holding Block. The INVO Procedure is a fertility treatment option allowing fertilization and early embryo development to take place inside the woman's body. The INVO Procedure is an IVC or in vivo incubation assisted reproduction technique available.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Invo Bioscience Inc stock information, including NASDAQ:INVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INVO stock methods without spending real money on the virtual paper trading platform.